AstraZeneca: promising result for Pfizer vaccine



[ad_1]

In a Financial Times online health conference, Ruud Dober said that the first published data on the effectiveness of the vaccine did More optimistic that Astra could also follow up with its own positive results from the first clinical trials of its own vaccine.

AstraZeneca, which works with the University of Oxford, expects to report data on the final phase of clinical trials for COVID-19 immunization before the end of the year.



[ad_2]